CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis

Han-Sun Chiang, J. F. Lu, C. H. Liu, Y. N. Wu, C. C. Wu

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Chiang H-S, Lu J-F, Liu C-H, Wu Y-N, Wu C-C. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. As it is well established that an association exists between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis gene mutations, we investigated CFTR(TG)m(T)n polymorphism within a Taiwanese population that exhibits a very low incidence of CF. Sixty-three patients with CBAVD and 86 age-matched normal control subjects were evaluated. Temporal temperature gradient gel electrophoresis was used for CFTR mutational analysis. No major CFTR mutation was found in the patient series. A single prominent CFTR mutation, IVS8-5T, was present; however, (50.8% of 63 cases and 33.3% of 126 alleles), and exhibited a high prevalence of 12 or 13 TG repeats (93.8% of 32 cases and 95.2% of 42 alleles with IVS8-5T). Although these results are similar to those of Japanese CBAVD patients, they are higher than the common frequency (about 21%) found among Caucasian CBAVD patients. The very high percentage (42.9%) of patients with no CFTR mutations is also an ethnic characteristic. We concluded that CBAVD patients from Taiwan, who express a very low incidence of CF, were less affected by CFTR mutations, with the exception of IVS8-5T linked to either 12 or 13 TG repeats, which does exhibit a high prevalence among CBAVD patients tested.

Original languageEnglish
Pages (from-to)282-286
Number of pages5
JournalClinical Genetics
Volume76
Issue number3
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Cystic Fibrosis
Incidence
Population
Mutation
Alleles
Denaturing Gradient Gel Electrophoresis
Congenital bilateral aplasia of vas deferens
Taiwan
Genes

Keywords

  • Congenital bilateral absence of the vas deferens
  • Cystic fibrosis
  • Cystic fibrosis transmembrane conductance regulator
  • Male infertility
  • Sweat chloride

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. / Chiang, Han-Sun; Lu, J. F.; Liu, C. H.; Wu, Y. N.; Wu, C. C.

In: Clinical Genetics, Vol. 76, No. 3, 09.2009, p. 282-286.

Research output: Contribution to journalArticle

Chiang, Han-Sun ; Lu, J. F. ; Liu, C. H. ; Wu, Y. N. ; Wu, C. C. / CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. In: Clinical Genetics. 2009 ; Vol. 76, No. 3. pp. 282-286.
@article{c6a0934a40b94f1db296cb7572b4a9cb,
title = "CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis",
abstract = "Chiang H-S, Lu J-F, Liu C-H, Wu Y-N, Wu C-C. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. As it is well established that an association exists between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis gene mutations, we investigated CFTR(TG)m(T)n polymorphism within a Taiwanese population that exhibits a very low incidence of CF. Sixty-three patients with CBAVD and 86 age-matched normal control subjects were evaluated. Temporal temperature gradient gel electrophoresis was used for CFTR mutational analysis. No major CFTR mutation was found in the patient series. A single prominent CFTR mutation, IVS8-5T, was present; however, (50.8{\%} of 63 cases and 33.3{\%} of 126 alleles), and exhibited a high prevalence of 12 or 13 TG repeats (93.8{\%} of 32 cases and 95.2{\%} of 42 alleles with IVS8-5T). Although these results are similar to those of Japanese CBAVD patients, they are higher than the common frequency (about 21{\%}) found among Caucasian CBAVD patients. The very high percentage (42.9{\%}) of patients with no CFTR mutations is also an ethnic characteristic. We concluded that CBAVD patients from Taiwan, who express a very low incidence of CF, were less affected by CFTR mutations, with the exception of IVS8-5T linked to either 12 or 13 TG repeats, which does exhibit a high prevalence among CBAVD patients tested.",
keywords = "Congenital bilateral absence of the vas deferens, Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Male infertility, Sweat chloride",
author = "Han-Sun Chiang and Lu, {J. F.} and Liu, {C. H.} and Wu, {Y. N.} and Wu, {C. C.}",
year = "2009",
month = "9",
doi = "10.1111/j.1399-0004.2009.01258.x",
language = "English",
volume = "76",
pages = "282--286",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis

AU - Chiang, Han-Sun

AU - Lu, J. F.

AU - Liu, C. H.

AU - Wu, Y. N.

AU - Wu, C. C.

PY - 2009/9

Y1 - 2009/9

N2 - Chiang H-S, Lu J-F, Liu C-H, Wu Y-N, Wu C-C. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. As it is well established that an association exists between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis gene mutations, we investigated CFTR(TG)m(T)n polymorphism within a Taiwanese population that exhibits a very low incidence of CF. Sixty-three patients with CBAVD and 86 age-matched normal control subjects were evaluated. Temporal temperature gradient gel electrophoresis was used for CFTR mutational analysis. No major CFTR mutation was found in the patient series. A single prominent CFTR mutation, IVS8-5T, was present; however, (50.8% of 63 cases and 33.3% of 126 alleles), and exhibited a high prevalence of 12 or 13 TG repeats (93.8% of 32 cases and 95.2% of 42 alleles with IVS8-5T). Although these results are similar to those of Japanese CBAVD patients, they are higher than the common frequency (about 21%) found among Caucasian CBAVD patients. The very high percentage (42.9%) of patients with no CFTR mutations is also an ethnic characteristic. We concluded that CBAVD patients from Taiwan, who express a very low incidence of CF, were less affected by CFTR mutations, with the exception of IVS8-5T linked to either 12 or 13 TG repeats, which does exhibit a high prevalence among CBAVD patients tested.

AB - Chiang H-S, Lu J-F, Liu C-H, Wu Y-N, Wu C-C. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. As it is well established that an association exists between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis gene mutations, we investigated CFTR(TG)m(T)n polymorphism within a Taiwanese population that exhibits a very low incidence of CF. Sixty-three patients with CBAVD and 86 age-matched normal control subjects were evaluated. Temporal temperature gradient gel electrophoresis was used for CFTR mutational analysis. No major CFTR mutation was found in the patient series. A single prominent CFTR mutation, IVS8-5T, was present; however, (50.8% of 63 cases and 33.3% of 126 alleles), and exhibited a high prevalence of 12 or 13 TG repeats (93.8% of 32 cases and 95.2% of 42 alleles with IVS8-5T). Although these results are similar to those of Japanese CBAVD patients, they are higher than the common frequency (about 21%) found among Caucasian CBAVD patients. The very high percentage (42.9%) of patients with no CFTR mutations is also an ethnic characteristic. We concluded that CBAVD patients from Taiwan, who express a very low incidence of CF, were less affected by CFTR mutations, with the exception of IVS8-5T linked to either 12 or 13 TG repeats, which does exhibit a high prevalence among CBAVD patients tested.

KW - Congenital bilateral absence of the vas deferens

KW - Cystic fibrosis

KW - Cystic fibrosis transmembrane conductance regulator

KW - Male infertility

KW - Sweat chloride

UR - http://www.scopus.com/inward/record.url?scp=70350143207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350143207&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2009.01258.x

DO - 10.1111/j.1399-0004.2009.01258.x

M3 - Article

VL - 76

SP - 282

EP - 286

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 3

ER -